|
Working Papers
“The Economics
of Medical Procedure Innovation,” (with David Dranove, Christopher Heard, and
Bingxiao Wu), revise and resubmit Journal of Health Economics.
“Who Profits From
Amateurism: Rent-Sharing in Modern College Sports,” NBER Working Paper #27734
(with Jordan Keener Matthew J. Notowidigdo Nicole F. Ozminkowski)
“Endogenous Quality Investments in
the US Hospital Market,” NBER Working Paper #27440 (with Chris Ody and Amanda
Starc)
“The Impact of Private Contracting
on Healthcare for the Old and Sick: Evidence from California’s Medicaid
Program” (with Mark Duggan and Adelina Wang)
“Reinsuring the Insurers of Last
Resort” (with Chris Ody and David Dranove)
“Expected Profits and The
Scientific Novelty of Innovation,” NBER Working Paper #27093 \, (with David
Dranove and Manuel Hermosilla)
“The Opportunities and Limitations
of Monopsony Power in Healthcare: Evidence from the United States and
Canada,” July 2019 (with Jillian Chown, David Dranove, and Jordan Keener)
Guns and Violence: The Enduring
Impact of Crack Cocaine Markets on Young Black Males, NBER Working Paper
#24819, (with Bill Evans and Timothy J. Moore)
Pharmaceutical Profits and the
Social Value of Innovation, NBER Working Paper #20212, (with David Dranove
and Manuel Hermosilla)
Academic Publications
The Impact of Early Discharge Laws on the Health of
Newborns, (with William Evans and Heng Wei), Journal of Health Economics, 2008, 27: 843-870.
The Economic Benefits of Pharmaceutical Innovations:
The Case of Cox-2 Inhibitors, American
Economic Journal: Applied Economics 2012 4(3): 116-137.
The
Doctor Might See You Now: Supply Side Effects of Public Health Insurance
Expansions, American Economic Journal: Economic Policy
2012 4(3): 190-217.
Estimating Heterogeneity
in the Benefits of Medical Treatment Intensity (with William Evans), The Review of Economics and Statistics, 2012, 94(3): 635-649
Can Celebrity Endorsements Affect Political Outcomes? Evidence
from the 2008 U.S. Democratic Presidential Primary (with Timothy J. Moore), The Journal of Law, Economics, and
Organization, 2013, 29(2): 355-384.
Giving Mom a
Break: The Impact of Higher EITC Payments on Maternal Health (with William
Evans), American Economic Journal: Economic
Policy, 2014, 6(2): 258-290.
Demand Spillovers,
Combative Advertising, and Celebrity Endorsements, American Economic Journal: Applied
Economics, 2014, 6(2); 76-104.
Public Health Insurance,
Labor Supply, and Employment Lock (with Tal Gross and Matthew Notowidigdo), Quarterly
Journal of Economics, 2014, 129(2): 653-696.
The Impacts of the 2008 Economic Downturn on the Health
Spending of the Insured (with David Dranove and Christopher Ody), Health
Affairs, 2014, 33(8): 1399-1406.
The
Economic Downturn And Its Lingering Effects Reduced Medicare Spending Growth
By $4 Billion In 2009–12 (with David Dranove and Christopher Ody), Health
Affairs, 2015, 34(8): 1368-1375.
The Market
Impacts of Product Patents in Developing Countries: Evidence from India (with
Mark Duggan and Aparajita Goyal), American
Economic Review, 2016, 106(1): 99-135
Investment
Subsidies and the Adoption of Electronic Medical Records in Hospitals, (with
David Dranove, Chris Ody, and Bingyang Li), Journal
of Health Economics, 2016, 44: 309-319.
Uncompensated Care Decreased at Hospitals in Medicaid
Expansion States But Not At Hospitals in Nonexpansion
States (with David Dranove and Christopher Ody), Health Affairs, 2016,
35(8): 1471-1479.
The White/Black Educational Gap, Stalled Progress, and
the Long Term Consequences of the Emergence of Crack Cocaine Markets, (with
William Evans and Timothy J. Moore), The Review of Economics and
Statistics, 2016, 98(5): 832–847
Early Impact of the Affordable Care Act on Emergency
Department Use, (with John Graves, Tal Gross, and Matthew Notowidigdo),
Annals of Internal Medicine, Feb 7, 2017, 166(3):172-179
How Do Hospitals Respond to Negative Financial Shocks? The
Impact of the 2008 Stock Market Crash (with David Dranove and Christopher
Ody), The RAND Journal of Economics, 2017, 48(2): 485–525.
Success and Failure in the Insurance Exchanges (with
John Graves), New England Journal of Medicine, March 9, 2017,
376(10):907-910
The Economics of Indication Based Pricing (with Amitabh
Chandra), New England Journal of Medicine, July 2017, 377(2):103-106.
Hospitals
as Insurers of Last Resort, (with Tal Gross and Matthew Notowidigdo),
American Economic Journal: Applied Economics, 2018, 10(1): 1-39.
The
CVS–Aetna Merger: Another Large Bet on the Changing U.S. Health Care
Landscape (with Austin Frakt), Annals of Internal Medicine, January 9,
2018.
The Orphan Drug Act at 35: Observations and an Outlook
for the Twenty-First Century, (with Nicholas Bagley, Benjamin Berger, Amitabh
Chandra, and Ariel D. Stern) in Innovation Policy and the Economy,
2018, Volume 19, pages 97-137, National Bureau of Economic Research, Inc.
Characterizing
the Drug Development Pipeline for Precision Medicine, (with Chandra, Amitabh,
Garthwaite, Craig and Stern, Ariel Dora Stern), Economic Dimensions of
Personalized and Precision Medicine, 2018, National Bureau of Economic
Research, Inc.
It’s Time to Reform the Orphan Drug Act (with Nicholas
Bagley, Amitabh Chandra, and Ariel D. Stern), NEJM Catalyst, Dec 19,
2018.
Economic
Principles for Medicare Reform (with Amitabh Chandra), ANNALS of the
American Academy of Political and Social Science, volume 686, 2019.
“All Medicaid Expansions
Are Not Created Equal: The Geography and Targeting of the Affordable Care
Act,” forthcoming Brookings Papers on Economic Activity, August 2019
(with John Graves, Tal Gross, Zeynal Karaca, Victoria Marone, and Matthew
Notowidigdo)
“The
Economics of Medicare for All,” book chapter in Maintaining the Strength
of American Capitalism published by the Aspen Economic Strategy Group,
eds. Melissa Kearney and Amy Ganz, December 2019.
“Insurance
access and demand response: Price and welfare implications,” (with David
Dranove and David Besanko), Journal of Health Economics, 2020, 73.
Congressional Testimony
Testimony, United
States House of Representatives, 2018
· House
Judiciary Committee, Subcommittee on Regulatory Reform, Commercial and
Antitrust Law: “Competition in the Pharmaceutical
Supply Chain: The Proposed Merger of CVS Health and Aetna”
Testimony, United
States House of Representatives, 2019
· House
Judiciary Committee, Subcommittee on Regulatory Reform, Commercial and
Antitrust Law: “Diagnosing the Problem:
Exploring the Effects of Consolidation and Anticompetitive Conduct in Health
Care Markets”
Testimony, United
States Senate, 2019
· Senate
Judiciary Committee, Subcommittee on Antirust, Competition Policy, and
Consumer Rights: “Your
Doctor/Pharmacist/Insurer Will See You Now: Competitive Implications of
Vertical Consolidation in the Healthcare Industry”
Testimony, United
States House of Representatives, 2019
· House
Education and Labor Committee, Subcommittee on Health, Education, Labor and
Pensions: “Making Health Care More Affordable: Lowering Drug
Prices and Increasing Transparency”
Permanent Working Papers
The Effect of In-Utero Conditions on Long Term
Health: Evidence from the 1918 Spanish
Flu Pandemic, May 2008 (First Draft: July, 2007)
Other Publications
A Floor-and-Trade Proposal to Improve the Delivery of
Charity‑Care Services
by U.S. Nonprofit Hospitals, (with David Dranove and Christopher Ody), The Hamilton Project Discussion Paper
Series, 2015.
Empirical Evidence on the Value of Pharmaceuticals,
(with Mark Duggan), in The [Oxford]
Handbook
of the Economics of the Biopharmaceutical Industry, 2012.
Starbucks: A Story of Growth, (with Jen Brown and Meghan Busse),
2011. Kellogg Case #5-211-259.
The Global Aircraft Manufacturing Industry, 2002-2011 (with Jen Brown), 2012.
Kellogg Case #5-312-505.
Sovaldi: Pricing a Breakthrough Drug, (with Meghan Busse), 2015, Kellogg Case.
|
